Furthermore, as high levels of IGF2 have been linked to a poorer prognosis in breast cancer (29) and we find that IGF-II drives proinvasive autocrine signaling in breast cancer cells, this opens up a new avenue for therapeutic intervention through IGF-II depletion. The gene discussed is IGF2; the disease is breast carcinoma.